البلد: إسرائيل
اللغة: الإنجليزية
المصدر: Ministry of Health
CINACALCET AS HYDROCHLORIDE
TARO INTERNATIONAL LTD, ISRAEL
H05BX01
FILM COATED TABLETS
CINACALCET AS HYDROCHLORIDE 90 MG
PER OS
Required
SYNTHON B.V., NETHERLANDS
CINACALCET
Treatment of secondary hyperparathyroidism (HPT) in patients with end-stage renal disease (ESRD) on maintenance dialysis therapy. Cinacalcet Taro may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma. Reduction of hypercalcaemia in patients with: • parathyroid carcinoma. • primary HPT for whom parathyroidectomy would be indicated on the basis of serum calcium levels (as defined by relevant treatment guidelines), but in whom parathyroidectomy is not clinically appropriate or is contraindicated.
2023-10-31
This Patient leaflet was formatted according to Ministry of Health guidelines. It was reviewed and approved by the Ministry of Health in November 2018 PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS (PREPARATIONS) - 1986 The dispensing of this medicine requires a doctor's prescription CINACALCET TARO FILM-COATED TABLETS 30 MG, 60 MG, 90 MG ACTIVE INGREDIENT AND ITS QUANTITY Each film-coated tablet contains 30 mg, 60 mg or 90 mg of cinacalcet (as hydrochloride). INACTIVE INGREDIENTS AND ALLERGENS: SEE SECTION 6 'ADDITIONAL INFORMATION'. READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. This leaflet contains essential information about the medicine. If you have any further questions, consult your doctor or pharmacist. This medicine has been prescribed to treat your illness. Do not pass it on to others. It may harm them, even if it seems to you that their illness is similar to yours. THIS MEDICINE IS NOT FOR USE IN CHILDREN AND ADOLESCENTS UNDER 18 YEARS OF AGE. 1. WHAT IS THIS MEDICINE INTENDED FOR? Cinacalcet Taro is used: to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products. to reduce high levels of calcium in the blood (hypercalcemia) in patients with parathyroid cancer. to reduce high levels of calcium in the blood (hypercalcemia) in patients with primary hyperparathyroidism when removal of the gland is not possible. THERAPEUTIC GROUP: Cinacalcet Taro is a calcimimetic agent. Cinacalcet Taro works by controlling the levels of parathyroid hormone (PTH), calcium, and phosphorous in your body. It is used to treat problems with organs called parathyroid glands. The parathyroids are four small glands in the neck, near the thyroid gland, that produce parathyroid hormone (PTH). In primary and secondary hyperparathyroidism too much PTH is produced by the parathyroid glands. 'Primary' means that the hyperparathyroidism is not caused by any other condition and 'secondary' means that the hyp اقرأ الوثيقة كاملة